Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer
Racially-associated MRI analysis and modeling for predicting aggressive prostate cancer
批准号:
10659602
负责人:
Harrison Kim
金额:
$57.78万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-15 至 2028-08-31
关键词:
3D PrintAddressAfrican AmericanAfrican American populationAgeAlabamaAnatomyAttentionBiopsyBlood VesselsCaliforniaCancerousCharacteristicsClinicalComputer softwareDataData SetDetectionDiagnosticEthnic OriginEthnic PopulationExtracellular SpaceImageImaging TechniquesIncidenceInformation SystemsInstitutionLesionLinkLos AngelesMagnetic Resonance ImagingMalignant neoplasm of prostateMeasurementMeasuresModelingMoldsNamesNeoplasm MetastasisPathologicPathologyPatientsPerformancePerfusionPeripheralProspective cohortProstateProstate-Specific AntigenProstatic NeoplasmsRaceRadical ProstatectomyRadiology SpecialtyReportingReproducibilityRiskScheduleSchemeScreening for Prostate CancerSpecific qualifier valueSpecificityStandardizationTestingTissuesUnited StatesUniversitiesalgorithm developmentcancer diagnosiscaucasian Americanclinical research siteclinically significantcontrast enhanceddeep learning algorithmdeep learning modeldensitydigitalearly onsetimprovedmenmortalitynon-invasive imagingpoint of careportabilitypredictive modelingracial disparityrecruittumortumor microenvironment
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
African American (AA) men have the highest incidence and mortality rate from prostate cancer (PCa) in the
United States. Prostate multi-parametric MRI (mpMRI) is a non-invasive imaging technique that can sensitively
detect prostate tumors by integrating anatomical and functional information. The current standardized scheme
for interpreting mpMRI is the Prostate Imaging Reporting and Data System (PI-RADS). However, detecting
cancerous lesions currently does not account for racially associated MRI characteristics in PI-RADS.
Our preliminary data showed a significant difference in detecting clinically significant PCa (csPCa) between AA
and CA men using PI-RADS when the tumors are in the transition zone (67% vs. 80%, respectively, p=0.026).
In addition, there was a distinctive difference in the PCa perfusion (that is, Ktrans) between AA and CA men, when
measured by quantitative dynamic contrast-enhanced MRI (qDCE). When PI-RADS-based interpretation was
combined with the Ktrans threshold value specified for AA men, the csPCa detection rate in the transition zone in
AA men was improved to 76%, becoming not statistically different from that in CA men (p=0.180).
We developed a point-of-care portable perfusion phantom named P4 to improve the reproducibility of qDCE
measurement across different institutes. The P4-based error correction significantly reduced the variability in
qDCE measurement across three MRI scanners in two institutes and improved the specificity of Ktrans for csPCa
detection from 86% to 93%. We hypothesize that the racial disparity in PCa diagnosis can be reduced by using
racially associated qDCE measurement after P4-based error correction.
We propose to test this hypothesis in a multi-institutional setting at the University of California, Los Angeles
(UCLA) and the University of Alabama at Birmingham (UAB). Our team will collect and link clinical, radiologic,
and histopathologic information using patient-specific 3D-printed prostate molds, software registration, and
expert annotation before and after radical prostatectomy. The highly curated radiology-pathology dataset will be
used (1) to characterize the qDCE measurement associated with tumor microenvironment in AA and CA groups,
using co-localized quantitative radiology-pathology analyses after P4-based error correction, (2) to investigate
whether the racially associated MRI-based tissue characterization improves the detection of aggressive PCa,
and (3) to develop the race/ethnicity-specific deep learning model for the improved detection of aggressive PCa.
When the Aims are successfully accomplished, the improved detection of PCa in both AA and CA men is
anticipated, compared to conventional strategies, reducing the racial disparity in detecting aggressive PCa.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Accurate DCE-MRI Measurement of Glioblastoma using Point-of-care Portable Perfusion Phantom
-
批准号:10377323
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2021
-
负责人:Harrison Kim
-
依托单位:
Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
-
批准号:10442823
-
项目类别:
-
资助金额:$50.03万
-
财政年份:2019
-
负责人:Harrison Kim
-
依托单位:
Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
-
批准号:10663915
-
项目类别:
-
资助金额:$44.06万
-
财政年份:2019
-
负责人:Harrison Kim
-
依托单位:
Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
-
批准号:10464911
-
项目类别:
-
资助金额:$47.98万
-
财政年份:2019
-
负责人:Harrison Kim
-
依托单位:
海外基金